Patrick Plewman compensation by year
QUEST DIAGNOSTICS Summary Compensation Table · the one fiscal year held| Component | FY2022 |
|---|---|
| Salary | $512,104 |
| Bonus | $0 |
| Stock awards | $728,227 |
| Option awards | $249,758 |
| Non-equity incentive | $441,276 |
| Pension and deferred compensation | $0 |
| All other | $48,579 |
| Total | $1,979,943 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: QUEST DIAGNOSTICS INC DEF 14A filed April 6, 2023, accession 0000930413-23-001199, and prior-year filings.
How this page was built: the QUEST DIAGNOSTICS INC filed document, accession 0000930413-23-001199. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 2,927 | $457,900 | — |
| PSU | 1,869 | $292,386 | — |
| PSU | 1,756 | $274,709 | — |
| PSU | 1,287 | $201,338 | — |
| RSU | 952 | $148,931 | — |
| RSU | 881 | $137,824 | — |
| RSU | 674 | $105,441 | — |
| Option | 4,274 | — | $127.73 |
| Option | 2,266 | — | $112.17 |
| Option | 3,775 | — | $121.81 |
| Option | 4,313 | — | $144.47 |
Per the Outstanding Equity Awards at Fiscal Year-End table in QUEST DIAGNOSTICS INC's FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
60 Form 4 lines since the FY2022 proxy (filed April 6, 2023)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion derivative | 10b5-1 | 6,793 | $127.81 | 3,397 |
| 2026-11-09 | Exercise or conversion derivative | 10b5-1 | 4,274 | $127.72 | 0 |
| 2026-11-09 | Exercise or conversion | 10b5-1 | 6,793 | $127.81 | 22,127 |
| 2026-11-09 | Sale | 10b5-1 | 4,274 | $257.34 | 15,334 |
| 2026-11-09 | Sale | 10b5-1 | 6,793 | $257.34 | 15,334 |
| 2026-11-09 | Sale | 10b5-1 | 650 | $257.34 | 14,684 |
| 2026-11-09 | Exercise or conversion | 10b5-1 | 4,274 | $127.72 | 19,608 |
| 2026-10-21 | L | — | 41 | $235.94 | 15,334 |
The 8 most recent of 60 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
QUEST DIAGNOSTICS’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Stephen Rusckowski | Former Chairman, Chief Executive Officer and President | $15,678,164 |
| James Davis | Chairman, Chief Executive Officer and President | $11,883,027 |
| Sam Samad | Executive Vice President and Chief Financial Officer | $6,268,982 |
| Carrie Manner | Former Senior Vice President, Advanced and General Diagnostics and Clinical Solutions | $4,211,531 |
| Catherine Doherty | Senior Vice President, Regional Businesses | $2,873,309 |
| Mark Guinan | Former Executive Vice President and Chief Financial Officer | $2,541,409 |
| Michael Prevoznik | Senior Vice President and General Counsel | $2,443,300 |
| Patrick Plewman · this page | Senior Vice President, Diagnostic Services | $1,979,943 |
The full QUEST DIAGNOSTICS compensation record
free company briefThis page is one person within QUEST DIAGNOSTICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the QUEST DIAGNOSTICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are QUEST DIAGNOSTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.